Pancytopenia and cough in a man with amyopathic dermatomyositis.
Geisel School of Medicine at Dartmouth, Hanover, and Dartmouth-Hitchcock Medical Center and The Dartmouth Institute for Health Policy & Clinical Practice, Lebanon, New Hampshire.
John N
JN
Mecchella
William F C
WF
Rigby
Alicia J
AJ
Zbehlik
D000890:Anti-Infective Agents / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects; D041001:Babesia microti / Q000276:immunology / Q000302:isolation & purification*; D001404:Babesiosis / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000469:parasitology*; D003371:Cough / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000469:parasitology*; D003882:Dermatomyositis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects; D017563:Lung Diseases, Interstitial / Q000209:etiology; D008297:Male; D008875:Middle Aged; D010198:Pancytopenia / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000469:parasitology*; D012307:Risk Factors; D000069283:Rituximab; D013997:Time Factors; D016896:Treatment Outcome
D000890:Anti-Infective Agents; D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; D000069283:Rituximab